HuaTeng Biotechnology
PrivateLast Round
Series A
Extension
Jan 1, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
HuaTeng Biotechnology operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series A Extension round in January 2026.
HuaTeng Biotechnology is a preclinical contract research organization (CRO) that provides drug discovery, medical device evaluation, and translational research services through GLP-compliant animal models and laboratory platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HuaTeng Biotechnology Comparables
Compare HuaTeng Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaLegacy | 83% | |
| Noble Life Sciences | 82% | |
| Cyagen Biosciences | 81% |
For institutional investors. Book with your work email.
HuaTeng Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 1, 2026 | ||||
| Series B | Sep 21, 2024 | ||||
| Series A Extension | Aug 30, 2023 | ||||
| Series A | Sep 5, 2022 |
For institutional investors. Book with your work email.
HuaTeng Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 万联天泽资本投资有限公司 | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Completed a Series A Extension round.
- Sep 21, 2024
Completed Series B financing round.
For institutional investors. Book with your work email.
HuaTeng Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HuaTeng Biotechnology's valuation, stock price, and market status.
Is HuaTeng Biotechnology a public or private company?
HuaTeng Biotechnology is a private company.
What is the current stock price of HuaTeng Biotechnology?
HuaTeng Biotechnology is a private company, so its shares have no public market price. Caplight tracks HuaTeng Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HuaTeng Biotechnology worth (valuation)?
Valuation information for HuaTeng Biotechnology is not publicly available.
Can I buy HuaTeng Biotechnology stock?
HuaTeng Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HuaTeng Biotechnology's last funding round?
HuaTeng Biotechnology's most recent funding round was Series A Extension on January 1, 2026.
Who are the main investors in HuaTeng Biotechnology?
Key investors in HuaTeng Biotechnology include 万联天泽资本投资有限公司.
Will HuaTeng Biotechnology IPO soon?
No public IPO plans have been announced for HuaTeng Biotechnology.
How can I track HuaTeng Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in HuaTeng Biotechnology's shares on secondary markets.